Table 1. Patient and disease... | American Society of Hematology

Table 1.

Patient and disease characteristics

Patient No.	Age, y	Sex	AML FAB subtype/karyotype^*	Treatment history	Duration of first CR, mo	No. reinduction attempts
1	64	Male	M1/del(7)(q31), t(1;7)(q11;q22)	2nd relapse	17	1
2	73	Female	M1/tetrasomy 22	1st relapse	5	N/A
3	85	Female	Secondary/normal	Untreated	N/A	N/A
4	67	Male	Secondary, M5/del(7)(p22)	1st relapse	6	N/A
5	69	Female	M1/normal	1st relapse	30	N/A
6	62	Female	M2/normal	2nd relapse	31	2
7	78	Female	Secondary, M1/normal	Untreated	N/A	N/A
8	76	Male	Secondary/^†	1st relapse	19	N/A
9	68	Male	Secondary, M1/del(5q)	Refractory	N/A	N/A
10	62	Male	Secondary/^†	Untreated	N/A	N/A
11	72	Male	Secondary, M4/^†	Refractory	N/A	N/A
12	65	Male	M7/del(7)(q22)	2nd relapse	58	2
13	64	Female	M4/del(9p)	2nd relapse	15	2
14	82	Female	M1/^†	Untreated	N/A	N/A
15	82	Female	M6/^†	Untreated	N/A	N/A
16	69	Male	Secondary, M4/^†	Refractory	N/A	N/A
17	58	Male	Secondary, M6/complex	1st relapse	5	N/A
18	68	Male	Secondary, M5/^†	Untreated	N/A	N/A
19	63	Female	M2/inv(3q), del(7)(q31)	1st relapse	8	N/A
20	79	Female	M5/normal	1st relapse	2	N/A

Patient No.	Age, y	Sex	AML FAB subtype/karyotype^*	Treatment history	Duration of first CR, mo	No. reinduction attempts
1	64	Male	M1/del(7)(q31), t(1;7)(q11;q22)	2nd relapse	17	1
2	73	Female	M1/tetrasomy 22	1st relapse	5	N/A
3	85	Female	Secondary/normal	Untreated	N/A	N/A
4	67	Male	Secondary, M5/del(7)(p22)	1st relapse	6	N/A
5	69	Female	M1/normal	1st relapse	30	N/A
6	62	Female	M2/normal	2nd relapse	31	2
7	78	Female	Secondary, M1/normal	Untreated	N/A	N/A
8	76	Male	Secondary/^†	1st relapse	19	N/A
9	68	Male	Secondary, M1/del(5q)	Refractory	N/A	N/A
10	62	Male	Secondary/^†	Untreated	N/A	N/A
11	72	Male	Secondary, M4/^†	Refractory	N/A	N/A
12	65	Male	M7/del(7)(q22)	2nd relapse	58	2
13	64	Female	M4/del(9p)	2nd relapse	15	2
14	82	Female	M1/^†	Untreated	N/A	N/A
15	82	Female	M6/^†	Untreated	N/A	N/A
16	69	Male	Secondary, M4/^†	Refractory	N/A	N/A
17	58	Male	Secondary, M6/complex	1st relapse	5	N/A
18	68	Male	Secondary, M5/^†	Untreated	N/A	N/A
19	63	Female	M2/inv(3q), del(7)(q31)	1st relapse	8	N/A
20	79	Female	M5/normal	1st relapse	2	N/A

AML indicates acute myeloid leukemia; FAB, French-American-British classification, N/A, not applicable.

See Bennett et al.13

Not available.